More than half of surveyed IT professionals said monitoring data cost more than the infrastructure being watched, while many struggled to measure AI performance
PerturbAI, an AI-native biotechnology company, today announced results from its year-long collaboration with OpenAI to advance biomedical research and drug discovery. Working with Scripps Research, the teams developed an AI reasoning framework that helps scientists interpret large experimental datasets,
Surface electromyography (sEMG)-based silent speech interfaces are limited by cross-user variability and calibration burden. We study a limited-data setting in which each of 27 speech-typical participants contributed less than 0.5 h of data (21.3 min on average) across Aloud…
Long-running AI agents outlive initiating processes through credentials, delegated tasks, queues, callbacks, reservations, and provider-side operations. Cancellation, process exit, and credential revocation neither close every pre-cut carrier nor distinguish independently…
Embedding-based retrieval on user-generated content at the trillion-document scale exposes a sharp conflict between two production demands: deep, expressive personalization for queries with rich user intent, and broad coverage of a massive inventory under fixed latency and…
Drug mechanism-of-action (MoA) modeling commonly relies on perturbational transcriptomes, but matched microRNA (miRNA) measurements are often unavailable. Inferred regulatory features offer a scalable way to reuse these data. Here, we present MIRCID, a framework comparing gene…